Navigate
X
    QualityStocks
  • 18 years ago

CytRx Corporation (NASDAQ: CYTR)

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company, is focused on developing high-value human therapeutics. Their drug development pipeline includes six programs in clinical development. The Company owns and operates a research and development facility in San Diego, California, and holds a 45% equity interest in RXi Pharmaceuticals (NasdaqCM: RXII ). For further information, visit the Company’s web site at www.cytrx.com.

Tags Rodman & Renshaw
Related Post
  1. QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

    Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…

  2. Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform

    WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…

  3. Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment

    Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…